People · Operator
Named in public records as an officer, director or promoter · active 2010–2021 · Biotech / Pharma, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Alto Pharmacy Holdings, Inc. | — | Biotech / Pharma | Series D+ | $169.7M | $3.1B | 2021 |
| Demandbase, Inc. | — | Other Technology | Series C | $108.2M | $1.5B | 2017 |
| Intacct Corp | — | Other Technology | Series B | $40.5M | $913.7M | 2010 |
| Crownpeak Technology | — | Other Technology | Seed | $1.8M | $59.6M | 2010 |
ROBERT SPINNER at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside ROBERT SPINNER on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| GREGORY SANDS | 2 | 7 |
| Byron Deeter | 1 | 17 |
| Brian Jacobs | 1 | 9 |
| Stacey Bishop | 1 | 9 |
| Anthony Lee | 1 | 8 |
| JEFF EPSTEIN | 1 | 6 |
| Edward Gilhuly | 1 | 6 |
| ROBERT REID | 1 | 5 |
| David Karnstedt | 1 | 4 |
| Kevin Burns | 1 | 4 |
| Neil Shah | 1 | 4 |
| Nichola Eliovits | 1 | 4 |
| Troy Fukumoto | 1 | 4 |
| Bryan Morris | 1 | 4 |
| Bob Spinner | 1 | 3 |
| Mattieu Gamache-Asselin | 1 | 2 |
| James Howard | 1 | 2 |
| Christopher Golec | 1 | 2 |
| CHELSEA STONER | 1 | 2 |
| JOHN DILLON | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.